. 2001 May;39(5):2009–2014. doi: 10.1128/JCM.39.5.2009-2014.2001

TABLE 3.

Oligonucleotides used in EMSA, genome positions, and TFBSs affected

Oligonucleotide^d	Nucleotide sequence (5′-3′)^a	Genome position (nt)	TFBS
AAYY1^a	CTAGATTGCGACATTTTGCG		AAV P5-60
AAVYY1R^a	CTAGACGCAAAATGTCGCAA		YY1
YY1P^a	CTAGATTCATACATGAACTG	7790–7804	YY1
YY1PR^a	CTAGACAGTTCATGTATGAA
YY1M	CTAGATTTATACATGAACTG
YY1MR	CTAGACAGTTCATGTATAAA
OCT1P^b	ATCACTATGCGCCAACGCCTTACATAC	7667–7693	Oct-1/PEF-1
OCT1PR^b	GTATGTAAGGCGTTGGCGCATAGTGAT
OCT1M	ATCACTATGAGCCAACGCCTTACATAC
OCT1MR	GTATGTAAGGCGTTGGCTCATAGTGAT
PSMP^c	AGATCTTATAATAATACTAAACTACAATAATTCAT	7893–15	PSM
PSMPR^c	AGATCTATGAATTATTGTAGTTTAGTATTATTATA
PSMM	AGATCTTCTAATAATACTAAACTACAATAATTCAT
PSMMR	AGATCTATGAATTATTGTAGTTTAGTATTATTAGA

Oligonucleotides published in reference 12.

Oligonucleotides published in reference 16.

Oligonucleotides published in reference 13.

P, Prototype; M, Mutant.

Italics represent restriction endonuclease sites (XbaI for YY1 and BglII for PSM). Bold sequence indicates altered nucleotides.